Cargando…

Re-Inventing Yourself after Spinal Cord Injury: A Site-Specific Randomized Clinical Trial

STUDY DESIGN: Parallel-arm randomized controlled trial comparing an interactive group format versus a no-intervention control. OBJECTIVE: To evaluate the efficacy of a replicable group treatment program for improving self-efficacy after spinal cord injury (SCI) in a single center cohort of adults. S...

Descripción completa

Detalles Bibliográficos
Autores principales: Coker, Jennifer, Cuthbert, Jeffrey, Ketchum, Jessica M., Holicky, Richard, Huston, Toby, Charlifue, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451659/
https://www.ncbi.nlm.nih.gov/pubmed/30573769
http://dx.doi.org/10.1038/s41393-018-0230-8
_version_ 1783409197606502400
author Coker, Jennifer
Cuthbert, Jeffrey
Ketchum, Jessica M.
Holicky, Richard
Huston, Toby
Charlifue, Susan
author_facet Coker, Jennifer
Cuthbert, Jeffrey
Ketchum, Jessica M.
Holicky, Richard
Huston, Toby
Charlifue, Susan
author_sort Coker, Jennifer
collection PubMed
description STUDY DESIGN: Parallel-arm randomized controlled trial comparing an interactive group format versus a no-intervention control. OBJECTIVE: To evaluate the efficacy of a replicable group treatment program for improving self-efficacy after spinal cord injury (SCI) in a single center cohort of adults. SETTING: Regional SCI center. METHODS: Participants included 81 individuals with SCI who were at least 4 weeks post-discharge from initial rehabilitation. Those randomized to treatment participated in six interactive learning sessions (2 hours each, one session per week) with structured and facilitated group interactions to improve self-efficacy. A wait-list control group was followed at matching time points for all outcome measures. The primary outcome measure was the Moorong Self-Efficacy Scale (MSES); secondary outcomes were the Generalized Self-Efficacy Scale (GSES); Diener Satisfaction with Life Scale (SWLS); Participation Assessment with Recombined Tools – Objective (PART-O); Patient Health Questionnaire – 9 (PHQ-9); and General Anxiety Disorder 7-item (GAD-7). RESULTS: Individuals in the Treatment group had greater increases in MSES scores from baseline to immediately post-intervention (6 weeks) than the Control group, but that difference did not remain significant after controlling for multiple comparisons. However the improvement in the treatment group relative to the control group was not maintained through follow-up at 30 weeks. There was no evidence of an immediate or sustained treatment effect on any of the secondary outcomes. CONCLUSIONS: Self-efficacy improved for participants with SCI in the Treatment group, however, this improvement was not significant or maintained on follow-up.
format Online
Article
Text
id pubmed-6451659
institution National Center for Biotechnology Information
language English
publishDate 2018
record_format MEDLINE/PubMed
spelling pubmed-64516592019-10-01 Re-Inventing Yourself after Spinal Cord Injury: A Site-Specific Randomized Clinical Trial Coker, Jennifer Cuthbert, Jeffrey Ketchum, Jessica M. Holicky, Richard Huston, Toby Charlifue, Susan Spinal Cord Article STUDY DESIGN: Parallel-arm randomized controlled trial comparing an interactive group format versus a no-intervention control. OBJECTIVE: To evaluate the efficacy of a replicable group treatment program for improving self-efficacy after spinal cord injury (SCI) in a single center cohort of adults. SETTING: Regional SCI center. METHODS: Participants included 81 individuals with SCI who were at least 4 weeks post-discharge from initial rehabilitation. Those randomized to treatment participated in six interactive learning sessions (2 hours each, one session per week) with structured and facilitated group interactions to improve self-efficacy. A wait-list control group was followed at matching time points for all outcome measures. The primary outcome measure was the Moorong Self-Efficacy Scale (MSES); secondary outcomes were the Generalized Self-Efficacy Scale (GSES); Diener Satisfaction with Life Scale (SWLS); Participation Assessment with Recombined Tools – Objective (PART-O); Patient Health Questionnaire – 9 (PHQ-9); and General Anxiety Disorder 7-item (GAD-7). RESULTS: Individuals in the Treatment group had greater increases in MSES scores from baseline to immediately post-intervention (6 weeks) than the Control group, but that difference did not remain significant after controlling for multiple comparisons. However the improvement in the treatment group relative to the control group was not maintained through follow-up at 30 weeks. There was no evidence of an immediate or sustained treatment effect on any of the secondary outcomes. CONCLUSIONS: Self-efficacy improved for participants with SCI in the Treatment group, however, this improvement was not significant or maintained on follow-up. 2018-12-20 2019-04 /pmc/articles/PMC6451659/ /pubmed/30573769 http://dx.doi.org/10.1038/s41393-018-0230-8 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Coker, Jennifer
Cuthbert, Jeffrey
Ketchum, Jessica M.
Holicky, Richard
Huston, Toby
Charlifue, Susan
Re-Inventing Yourself after Spinal Cord Injury: A Site-Specific Randomized Clinical Trial
title Re-Inventing Yourself after Spinal Cord Injury: A Site-Specific Randomized Clinical Trial
title_full Re-Inventing Yourself after Spinal Cord Injury: A Site-Specific Randomized Clinical Trial
title_fullStr Re-Inventing Yourself after Spinal Cord Injury: A Site-Specific Randomized Clinical Trial
title_full_unstemmed Re-Inventing Yourself after Spinal Cord Injury: A Site-Specific Randomized Clinical Trial
title_short Re-Inventing Yourself after Spinal Cord Injury: A Site-Specific Randomized Clinical Trial
title_sort re-inventing yourself after spinal cord injury: a site-specific randomized clinical trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451659/
https://www.ncbi.nlm.nih.gov/pubmed/30573769
http://dx.doi.org/10.1038/s41393-018-0230-8
work_keys_str_mv AT cokerjennifer reinventingyourselfafterspinalcordinjuryasitespecificrandomizedclinicaltrial
AT cuthbertjeffrey reinventingyourselfafterspinalcordinjuryasitespecificrandomizedclinicaltrial
AT ketchumjessicam reinventingyourselfafterspinalcordinjuryasitespecificrandomizedclinicaltrial
AT holickyrichard reinventingyourselfafterspinalcordinjuryasitespecificrandomizedclinicaltrial
AT hustontoby reinventingyourselfafterspinalcordinjuryasitespecificrandomizedclinicaltrial
AT charlifuesusan reinventingyourselfafterspinalcordinjuryasitespecificrandomizedclinicaltrial